Antibody Drug Conjugates Are Being Investigated for the Treatment of Platinum-Resistant Ovarian Cancer

Targeted Oncology recently published a report citing a promising class of drugs to treat recurrent platinum-resistant ovarian cancer (PROC), often associated with a poor prognosis. PROC eventually occurs to a…

Continue Reading Antibody Drug Conjugates Are Being Investigated for the Treatment of Platinum-Resistant Ovarian Cancer